Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic LeukemiaShannon L. Maude, Stephan A. Grupp, Theodore W. Laetsch et al.|New England Journal of Medicine|2018Cited by 5.7k
The Molecular Basis of Turcot's SyndromeStanley R. Hamilton, Kenneth W. Kinzler, Fowzia Taqi et al.|New England Journal of Medicine|1995Cited by 1.1k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaElena J. Orlando, Wendy Winckler, Xia Han et al.|Nature Medicine|2018Cited by 577
Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)Stephan A. Grupp, Michael A. Pulsipher, Theodore W. Laetsch et al.|Blood|2016Cited by 83
Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim AnalysisJochen Buechner, Susana Rives, Stephan A. Grupp et al.|Clinical Lymphoma Myeloma & Leukemia|2017Cited by 63